Vaxneuvance™ Pneumococcal 15-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free 2 mcg - 4 mcg - 30 mcg / 0.5 mL Injection 0.5 mL

Name: Pneumonia Vaccine
Brand: Vaxneuvance™

VAXNEUVANCE, SYR 0.5ML (1/BX)

McKesson #

1199196

Manufacturer #

00006432902

Brand

Vaxneuvance™

Manufacturer

Merck

Country of Origin

Unknown

Application

Pneumonia Vaccine

Container Type

Prefilled Syringe

Dosage Form

Injection

Generic Drug Code

50034

Generic Drug Name

Pneumococcal 15-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free

NDC Number

00006432902

Storage Requirements

Requires Refrigeration

Strength

2 mcg - 4 mcg - 30 mcg / 0.5 mL

Type

Intramuscular

UNSPSC Code

51201615

User

Indicated for People 6 Weeks of Age and Older

Volume

0.5 mL

VAXNEUVANCE™ is a vaccine indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in individuals 6 weeks of age and older
Children: Administer VAXNEUVANCE as a 4-dose series at 2, 4, 6 and 12 through 15 months of age
Adults: Administer VAXNEUVANCE as a single dose in adults 18 years of age and older